Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

PROSHARES TRUST (ZBIO) EPS (Basic): 2023-2024

Historic EPS (Basic) for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to -$11.89.

  • Zenas BioPharma's EPS (Basic) rose 75.70% to -$1.22 in Q3 2025 from the same period last year, while for Sep 2025 it was $13.67, marking a year-over-year increase of 121.64%. This contributed to the annual value of -$11.89 for FY2024, which is 50.97% up from last year.
  • According to the latest figures from FY2024, Zenas BioPharma's EPS (Basic) is -$11.89, which was up 50.97% from -$24.25 recorded in FY2023.
  • In the past 5 years, Zenas BioPharma's EPS (Basic) registered a high of -$11.89 during FY2024, and its lowest value of -$24.25 during FY2023.
  • Over the past 2 years, Zenas BioPharma's median EPS (Basic) value was -$18.07 (recorded in 2023), while the average stood at -$18.07.
  • Data for Zenas BioPharma's EPS (Basic) shows a peak YoY skyrocketed of 50.97% (in 2024) over the last 5 years.
  • Over the past 2 years, Zenas BioPharma's EPS (Basic) (Yearly) stood at -$24.25 in 2023, then surged by 50.97% to -$11.89 in 2024.